AiCE (Canon Medical)

By Canon Medical
· Japan
Canon Medical — Deep-learning image reconstruction for CT and MRI (image quality, not detection/diagnosis).
Diagnostic
Radiology
Production
FDA Cleared
Regulatory status
FDA Cleared
Deployment
Production
Clinical role
Adjunct (decision support)
Headquarters
Japan
AI type
Diagnostic

Precise indication

Deep-learning image reconstruction for CT and MRI (image quality, not detection/diagnosis).

Regulatory status

Multiple FDA clearances confirmed for different product lines (Aquilion Precision CT, MRI).

Clinical evidence

Vendor-supported

Trade press coverage of the FDA clearance.

Independent

Not found in this research pass — verify before publishing.

Real-world deployment

Not independently quantified in this research pass.

Interoperability

European status

Editorial verdict

Limits and uncertainties

This is a reconstruction/image-quality technology, not a detection or diagnostic algorithm — do not conflate its clinical role with the other entries in this batch.

Sources

https://www.dicardiology.com/product/canon-medical-receives-fda-clearance-aice-reconstruction-technology-ct

This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate

At a glance
Vendor
Canon Medical
Headquarters
Japan
AI type
Diagnostic
Specialty
Clinical role
Adjunct (decision support)
CE marking
Notified body
EU AI Act
Data hosting
Last verified
Reviewed by
How we evaluate

Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.

A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.

Read the methodology →

Spotted an error?

Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.